Augmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria

Project Information

AIPGENE

Grant agreement ID: 261506

Project closed

Start date 1 January 2011

End date 31 October 2014

Funded under

• Specific Programme "Cooperation": Health

Total cost € 4 347 949,14

EU contribution € 3 308 154,00

Coordinated by

FUNDACION PARA LA INVESTIGACION MEDICA APLICADA FIMA
Spain